Medical News

RSS

May Assets in HSAs and HRAs grown to $7.1 billion in 2009: EBRI study

May Assets in health savings accounts and health reimbursement arrangements, two relatively new employment-based health benefit plan options , have grown in recent years and totaled $7.1 billion in 2009, up from $835.4 million three years earlier, according to a study published today by the nonpartisan Employee Benefit Research Institute.

2 Jun 2010

Aspirin may not be beneficial for young adults with diabetes

Experts are now recommending that low-dose aspirin therapy to prevent heart attacks be used somewhat more conservatively - that men younger than 50 and women younger than 60, who have diabetes but no other major risk factors, probably not use aspirin.

2 Jun 2010

Meditation-based therapies benefit patients with chronic pain

People who meditate regularly find pain less unpleasant because their brains anticipate the pain less, a new study has found.

2 Jun 2010

Researchers offer solutions for groundwater contamination crisis

Over 100 million people in rural southern Asia are exposed every day to unsafe levels of arsenic from the well-water they drink. It more than doubles their risks for cancer, causes cardiovascular disease, and inhibits the mental development of children, among other serious effects.

2 Jun 2010

Chronix Biomedical to launch new disease detection, monitoring service for cancer researchers at 2010 ASCO

Chronix Biomedical today announced that it will launch a new disease detection and monitoring service for cancer researchers at the upcoming 2010 ASCO Annual Meeting. The "For Investigational Use Only" laboratory-based testing service uses Chronix's breakthrough approach—the Chronix Apoptotic DNA Blood Test—which analyzes apoptotic DNA from dead and dying cells to identify and track ongoing changes associated with specific cancers and other chronic diseases.

2 Jun 2010

Patients at greatest risk of post-PCI bleeding least likely to receive bleeding avoidance strategies

In a study that included data from more than 1.5 million patients, use of vascular closure devices and the anticoagulant bivalirudin were associated with significantly lower bleeding rates for patients following a percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), according to a study in the June 2 issue of JAMA. The researchers also found that patients who may benefit most from these treatments, those at greatest risk of bleeding, were least likely to receive them.

2 Jun 2010

Research findings advance the effort to develop AIDS vaccine

In findings that contribute to efforts to design an AIDS vaccine, a team led by Scripps Research Institute scientists has determined the structure of an immune system antibody molecule that effectively acts against most strains of human immunodeficiency virus, the virus that causes AIDS.

2 Jun 2010

Protox Therapeutics reports positive data from Phase 2b study of PRX302 in BPH

Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive six month data from its double-blind placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH) a bothersome urologic condition that affects the quality of life of more than 50 million men worldwide.

2 Jun 2010

Researchers develop new technique to detect cathepsin K in atherosclerosis, cancer metastasis

An enzyme implicated in osteoporosis, arthritis, atherosclerosis and cancer metastasis -- cathepsin K -- eluded reliable detection in laboratory experiments in the past. Now, a research team at the Georgia Institute of Technology has developed an assay that reliably detects and quantifies mature cathepsin K using a technique called gelatin zymography.

2 Jun 2010

Johns Hopkins professor receives $1M MSCRF grant to study glial cells for treating myelin disorders

Q Therapeutics, Inc. announced today that Piotr Walczak, M.D., of Johns Hopkins University has received notification of a $1,000,000 grant to be awarded by the Maryland Stem Cell Research Fund (MSCRF) which will enable further study of Q's human neural glial cell product Q-Cells® in preclinical models of demyelinating disease.

2 Jun 2010

Concentric Medical receives expanded indication for DAC family of neurovascular catheters

Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced an important expanded indication for the full line of DAC™ Neurovascular Catheters. CE Mark was granted allowing the DAC family of distal access catheters to be used for the removal/aspiration of fresh, soft emboli and thrombi from vessels in the arterial system, including the neurovasculature.

2 Jun 2010

ENMD-2076 demonstrates antitumor activity against murine xenograft models of CRC: Study

EntreMed, Inc., today announced the publication of preclinical results for its clinical-stage Aurora A/angiogenic kinase inhibitor, ENMD-2076, in human colorectal cancer xenograft models. The results of the study, conducted by EntreMed collaborators at the University of Colorado School of Medicine, were published in the June 1, 2010 issue of Clinical Cancer Research (Vol. 16, Issue 11).

2 Jun 2010

Biomoda, Obio sign MOU to establish CLIA-certified clinical laboratory in Ohio

Cancer diagnostics company Biomoda, Inc. and Obio, a corporation formed to pursue public and private funding for cancer research in Ohio, signed a memorandum of understanding to establish a CLIA-certified Biomoda clinical laboratory in Ohio to support ongoing research and development on Biomoda's porphyrin-based assay for the detection of early-stage cancer.

2 Jun 2010

Asuragen obtains license to integrate BRAF V600E mutation sequence into its molecular diagnostic products

Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.

2 Jun 2010

Constellation Pharmaceuticals raises $22 million in Series B financing round

Constellation Pharmaceuticals, Inc., the leading biopharmaceutical company focused on discovering and developing new drugs targeting epigenetic regulation of the human genome, today announced that it has raised $22 million in a Series B financing round.

2 Jun 2010

CDC data shows frequent binge drinkers more likely to report suboptimal self-rated health

Recent data from the Centers for Disease Control and Prevention show that excessive drinking is responsible for approximately 79,000 deaths annually in the United States. Binge drinking accounts for more than half of those deaths. A new study has looked at the frequency of binge drinking in relation to drinkers' own perceptions of their overall health status.

2 Jun 2010

First Edition: June 2, 2010

In today's news, insurance regulators fail to meet an early deadline for setting standards on premium spending rules within the new health law.

2 Jun 2010

AstraZeneca receives 2010 EcoLeadership Award for second consecutive year

AstraZeneca announced today it has received the 2010 EcoLeadership Award by the Alliance for Workplace Excellence for the second consecutive year. The EcoLeadership Award recognizes companies that demonstrate their commitment to environmental sustainability practices such as energy efficiency, waste minimization and water conservation.

2 Jun 2010

SAGES issues new practice guideline for surgical treatment of GERD

BARRX Medical Inc., a leader in the development of minimally invasive medical devices designed to remove precancerous tissue from within the gastrointestinal tract, reported today that the Society of American Gastrointestinal and Endoscopic Surgeons has issued a new practice guideline for the surgical treatment of gastroesophageal reflux disease. Left untreated, reflux of stomach contents such as acid and bile into the esophagus in GERD patients often leads to injury and chronic inflammation of the lining of the esophagus.

2 Jun 2010

SOFAR licenses Immersion's TouchSense haptics technology for use in ALF-X telesurgical robot system

Immersion Corporation, the leading developer and licensor of haptics technology, today announced that SOFAR S.p.A., a leading Italian manufacturer of medical devices for minimally invasive surgery, has obtained a license to Immersion's TouchSense haptics technology for use in its ALF-X (Advanced Laparoscopy through Force Reflection) telesurgical robot system.

2 Jun 2010

Medical News

May Assets in HSAs and HRAs grown to $7.1 billion in 2009: EBRI study

Aspirin may not be beneficial for young adults with diabetes

Meditation-based therapies benefit patients with chronic pain

Researchers offer solutions for groundwater contamination crisis

Chronix Biomedical to launch new disease detection, monitoring service for cancer researchers at 2010 ASCO

Patients at greatest risk of post-PCI bleeding least likely to receive bleeding avoidance strategies

Research findings advance the effort to develop AIDS vaccine

Protox Therapeutics reports positive data from Phase 2b study of PRX302 in BPH

Researchers develop new technique to detect cathepsin K in atherosclerosis, cancer metastasis

Johns Hopkins professor receives $1M MSCRF grant to study glial cells for treating myelin disorders

Concentric Medical receives expanded indication for DAC family of neurovascular catheters

ENMD-2076 demonstrates antitumor activity against murine xenograft models of CRC: Study

Biomoda, Obio sign MOU to establish CLIA-certified clinical laboratory in Ohio

Asuragen obtains license to integrate BRAF V600E mutation sequence into its molecular diagnostic products

Constellation Pharmaceuticals raises $22 million in Series B financing round

CDC data shows frequent binge drinkers more likely to report suboptimal self-rated health

First Edition: June 2, 2010

AstraZeneca receives 2010 EcoLeadership Award for second consecutive year

SAGES issues new practice guideline for surgical treatment of GERD

SOFAR licenses Immersion's TouchSense haptics technology for use in ALF-X telesurgical robot system

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News